Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Radiology ; 218(1): 255-60, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11152811

RESUMEN

PURPOSE: To investigate the use of activated charcoal to mark the biopsy site and needle track after large-core-needle breast biopsy. MATERIALS AND METHODS: Three hundred seventy-six consecutive patients (with 383 lesions) were referred for stereotactic breast biopsy. Two hundred forty-seven lesions were carbon marked when the need for surgery was likely. Patients who underwent marking were followed up for the results of surgery or mammography performed at our institution. Specimen sizes obtained by using the carbon mark were compared with sizes of consecutive biopsy specimens obtained after hook-wire localization. RESULTS: Carbon marking was well tolerated in all cases. All 132 surgeries performed at the authors' institution were successful in removing the marked target. Specimen sizes compared favorably with sizes of comparison hook-wire localization specimens. All 68 lesions followed mammographically revealed no changes that were attributable to the use of carbon. Two minor complications were observed. Two small cancers were completely removed at needle biopsy. CONCLUSION: Carbon marking is safe and effective for marking the biopsy site and needle track created by stereotactic large-core-needle biopsy of the breast. Marking eliminates the need for postprocedural needle localization. It remains effective when small lesions have been completely removed. This technique should be considered in properly selected cases by those performing large-core-needle biopsy of the breast.


Asunto(s)
Biopsia con Aguja/métodos , Mama/patología , Carbón Orgánico , Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/patología , Diseño de Equipo , Femenino , Estudios de Seguimiento , Humanos , Mamografía
2.
J Infect Dis ; 181(5): 1643-51, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10823764

RESUMEN

Persistent diarrhea (PD; duration >/=14 days) is a growing part of the global burden of diarrheal diseases. A 45-month prospective cohort study (with illness, nutritional, and microbiologic surveillance) was conducted in a shantytown in northeastern Brazil, to elucidate the epidemiology, nutritional impact, and causes of PD in early childhood (0-3 years of age). A nested case-control design was used to examine children's diarrhea burden and nutritional status before and after a first PD illness. PD illnesses accounted for 8% of episodes and 34% of days of diarrhea. First PD illnesses were preceded by a doubling of acute diarrhea burdens, were followed by further 2.6-3.5-fold increased diarrhea burdens for 18 months, and were associated with acute weight shortfalls. Exclusively breast-fed children had 8-fold lower diarrhea rates than did weaned children. PD-associated etiologic agents included Cryptosporidium, Giardia, enteric adenoviruses, and enterotoxigenic Escherichia coli. PD signals growth shortfalls and increased diarrhea burdens; children with PD merit extended support, and the illness warrants further study to elucidate its prevention, treatment, and impact.


Asunto(s)
Diarrea/epidemiología , Estado Nutricional , Infecciones Bacterianas/epidemiología , Brasil/epidemiología , Lactancia Materna , Estudios de Cohortes , Diarrea/microbiología , Diarrea/parasitología , Femenino , Humanos , Incidencia , Recién Nacido , Estudios Longitudinales , Enfermedades Parasitarias/epidemiología , Pobreza , Prevalencia , Estudios Prospectivos , Factores de Riesgo , Factores Socioeconómicos , Virosis/epidemiología
4.
Pediatrics ; 103(1): E3, 1999 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9917483

RESUMEN

CONTEXT: A tetravalent vaccine against rotavirus, the most commonly identified etiologic agent of viral gastroenteritis (GE), has recently been licensed for use in the United States. OBJECTIVE: To evaluate whether specific groups of infants might be at sufficiently high risk to warrant a focused rotavirus vaccine policy, we investigated perinatal risk factors for hospitalization with viral GE and rotavirus in the first year of life. DESIGN: Population-based, case-control study. SETTING: Washington State linked birth certificate and hospital discharge abstracts from 1987 through 1995. PATIENTS: Infants, 1 through 11 months of age, hospitalized for viral GE (N = 1606) were patients in this study. Control subjects were 8084 nonhospitalized infants, frequency-matched to patients on year of birth. PRIMARY OUTCOME MEASURE: Maternal and infant characteristics associated with infant hospitalization for viral GE. RESULTS: We found a significant association between birth weight and the risk for hospitalization. Very low birth weight infants (<1500 g) were at the highest risk (odds ratio [OR] 2.6; 95% confidence interval [CI]: 1.6,4.1);, low birth weight infants (1500-2499 g), at intermediate risk (OR 1.6; 95% CI: 1.3,2.1); and large infants (>4000 g), at reduced risk (OR 0.8; 95% CI: 0.6,0.9). Other characteristics associated with GE hospitalization were male gender (OR 1.4; 95% CI: 1.3,1.6); maternal smoking (OR 1.2; 95% CI: 1.1,1. 4); unmarried mother (OR 1.2; 95% CI: 1.1,1.4); Medicaid insurance (OR 1.4; 95% CI: 1.3,1.7); and maternal age <20 years (OR 1.2; 95% CI: 1.0,1.5). Infants born October through December were at decreased risk for hospitalization (OR 0.8; 95% CI: 0.7,0.9), as were infants born to Asian mothers (OR 0.5; 95% CI: 0.3,0.7), and infants born to mothers >34 years of age (OR 0.7; 95% CI: 0.6,0.9). Using these factors, the area under a receiver operating characteristic curve was 0.63. Therefore, to achieve a sensitivity of 90% in identifying high-risk infants, specificity would fall to 10%. Subanalyses of children admitted for viral GE during the peak of the Northwest rotavirus season (January to March) and children with confirmed rotavirus infection demonstrated similar risk factors and receiver operating characteristic curves. CONCLUSION: We conclude that a focused rotavirus vaccination policy using readily identifiable potential high-risk groups would be unlikely to prevent most infant hospitalizations associated with rotavirus infection. However, the safety of rotavirus vaccine in low birth weight and premature infants must be established, because these children appear to be at greater risk for hospitalization with viral GE and rotavirus.


Asunto(s)
Diarrea Infantil/epidemiología , Gastroenteritis/epidemiología , Hospitalización/estadística & datos numéricos , Infecciones por Rotavirus/epidemiología , Análisis de Varianza , Peso al Nacer , Estudios de Casos y Controles , Diarrea Infantil/etnología , Diarrea Infantil/virología , Femenino , Gastroenteritis/virología , Humanos , Lactante , Modelos Logísticos , Masculino , Edad Materna , Curva ROC , Estudios Retrospectivos , Factores de Riesgo , Infecciones por Rotavirus/etnología , Estaciones del Año , Sensibilidad y Especificidad , Washingtón/epidemiología
5.
Am J Trop Med Hyg ; 55(6): 693-7, 1996 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9025700

RESUMEN

Infection with the human pathogenic parasite Entamoeba histolytica has not been well-characterized in northeastern Brazil. In this study, the prevalence of E. histolytica infection in a slum in northeastern Brazil was assayed using an enzyme-linked immunosorbent assay (ELISA) for antibodies against the galactose/N-acetyl-D-galactosamine (Gal/GalNAc)-inhibitable adherence lectin of E. histolytica. Sera from a total of 335 individuals were examined for anti-Gal/GalNAc lectin antibodies. The overall seropositivity was 24.7%; 29.4% of females and 19.4% of males were positive. Among different age groups there was a peak of 40% positivity in the 6-14-year-old age group. There was also familial clustering of seropositivity. To examine colonization, stool samples from 155 people were examined microscopically for the presence of the parasite. Fourteen of 155 stools (9.0%) were identified as containing E. histolytica or nonpathogenic E. dispar. These 14 positive stools were analyzed with an ELISA that detects Gal/GalNAc lectin antigen and can distinguish between E. histolytica and E. dispar. Four stools (29%) were positive for E. histolytica and the remaining 10 were identified as E. dispar-positive. Although the overall colonization rate by microscopy was only 9%, with a third identified as E. histolytica, up to 40% of older children develop serologic evidence of having experienced pathogenic E. histolytica infection. The results of this study demonstrate that this community in northeastern Brazil is highly endemic for E. histolytica with infection rates similar to other developing nations.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Entamoeba histolytica/inmunología , Entamebiasis/epidemiología , Parasitosis Intestinales/epidemiología , Áreas de Pobreza , Adolescente , Adulto , Distribución por Edad , Anciano , Animales , Antígenos de Carbohidratos Asociados a Tumores/inmunología , Brasil/epidemiología , Niño , Preescolar , Entamoeba histolytica/química , Entamoeba histolytica/aislamiento & purificación , Heces/parasitología , Femenino , Humanos , Lactante , Lectinas/inmunología , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Seroepidemiológicos , Población Urbana
6.
Med Pediatr Oncol ; 14(1): 20-5, 1986.
Artículo en Inglés | MEDLINE | ID: mdl-3951395

RESUMEN

Computed tomography of the abdomen and pelvis has been used to stage early prostatic cancer. We investigated its value in monitoring tumor response in more advanced disease. Serial computed tomography of the abdomen and pelvis was obtained along with multiple other staging tests prior to treatment and at 3- to 4-month intervals thereafter in 32 patients with stage D2 tumor treated initially with combination chemotherapy and with hormones at progression. Pretreatment lymphography with follow-up abdominal films was also performed. Initial computed tomography of the abdomen and pelvis showed evidence of node metastases in 35% of patients while lymphography was positive in 54%. Among 19 patients with tumor response and 25 with progression, the results of treatment were objectively documented by improvement or worsening, respectively, in a mean of 5.1 and 5.0 other staging tests, exclusive of computed tomography. Computed tomography of the abdomen and pelvis improved in 85% of responding patients examined. Progression was confirmed by worsening of computed tomography in 32%. Although lymphography was often abnormal prior to treatment, in our hands it was not useful in serial monitoring of tumor status. We conclude that serial computed tomography of the abdomen and pelvis, when initially positive, is a useful test to document objectively tumor response and progression in disseminated prostatic cancer.


Asunto(s)
Neoplasias Abdominales/diagnóstico por imagen , Adenocarcinoma/diagnóstico por imagen , Neoplasias Pélvicas/diagnóstico por imagen , Neoplasias de la Próstata/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Neoplasias Abdominales/secundario , Adenocarcinoma/tratamiento farmacológico , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Estudios de Seguimiento , Humanos , Metástasis Linfática , Linfografía , Masculino , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias Pélvicas/secundario , Neoplasias de la Próstata/tratamiento farmacológico
7.
Radiology ; 146(2): 513-8, 1983 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-6294738

RESUMEN

Radionuclide bone scans and skeletal radiographs were obtained before and during combination chemotherapy or initial hormonal treatment in 46 patients with disseminated adenocarcinoma of the prostate. The purpose of the study was to determine the usefulness of these two modalities in evaluating tumor response to therapy. Prior to treatment, bone scans were positive in 44 patients (96%). In all but one patient either bone radiographs or bone marrow biopsy revealed evidence of osseous metastases. In 22 patients partial response to therapy was documented by a variety of other staging tests. Eleven of these patients showed concurrent or later improvement on bone scans; one showed improvement on a radiograph. "Flare phenomena" were observed relatively frequently since 23% of the scans and 50% of the radiographs showed worsening at the time of response. Bone scans revealed worsening in 79% of 33 patients with disease progression of extraosseous tumor; radiographs were equally sensitive (82% worsening). It is concluded that bone scans in particular are useful for monitoring tumor status in systemically treated patients with prostate cancer. However, because of the lack of sensitivity for response and paradoxical worsening with tumor regression in some patients, scans are not accurate enough to be employed as the sole test in following these patients.


Asunto(s)
Adenocarcinoma/terapia , Neoplasias Óseas/secundario , Neoplasias de la Próstata/terapia , Adenocarcinoma/diagnóstico , Adenocarcinoma/secundario , Anciano , Neoplasias Óseas/diagnóstico , Castración , Cisplatino/administración & dosificación , Ciclofosfamida/administración & dosificación , Difosfatos , Difosfonatos , Doxorrubicina/administración & dosificación , Quimioterapia Combinada , Humanos , Masculino , Persona de Mediana Edad , Tecnecio , Medronato de Tecnecio Tc 99m , Pirofosfato de Tecnecio Tc 99m
8.
Cancer ; 36(6): 2016-9, 1975 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1203858

RESUMEN

A segment of small intestine surgically removed from a man with intestinal obstruction was found to have coexisting regional enteritis and an invasive adenocarcinoma associated with an area of intraepithelial neoplasia. The cells of the adenocarcinoma and the intraepithelial neoplasia contained a tumor-associated surface antigen capable of reacting with an antiserum prepared against a colonic carcinoma. The importance of thorough sampling of specimens of regional enteritis in accurate reporting of the incidence of carcinoma is stressed, as is the use of immunohistologic techniques as an adjunct to the morphologic diagnosis of preinvasive neoplasia.


Asunto(s)
Adenocarcinoma/inmunología , Antígenos de Neoplasias/análisis , Enfermedad de Crohn/inmunología , Neoplasias Intestinales/inmunología , Intestino Delgado , Adenocarcinoma/complicaciones , Adenocarcinoma/patología , Anciano , Enfermedad de Crohn/complicaciones , Enfermedad de Crohn/patología , Humanos , Neoplasias Intestinales/complicaciones , Neoplasias Intestinales/patología , Intestino Delgado/inmunología , Intestino Delgado/patología , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA